Global Specimen Collection Kit Market – Industry Trends and Forecast to 2030

Specimen Collection Kit Market Analysis and Size

The two main factors expected to drive market growth are the rising demand for sample collection kit and the approval by authorities of new and sophisticated detection tests as a result of the global COVID-19 outbreak. Numerous mergers and collaborations have occurred to increase the production of sample test kits, which is one of the most significant and significant factors that will likely accelerate the growth of the sample collection kit market.

Data Bridge Market Research analyses that the specimen collection kit market which was USD 7.56 billion in 2022, is expected to reach USD 15.63 billion by 2030, at a CAGR of 9.5% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Specimen Collection Kit Market Scope and Segmentation  

Market Definition

Specimen collection refers to obtaining fluids or tissue for laboratory analysis or near-patient testing. Specimen or sample tracks refer to the process by which a patient's sample is labeled and sent for testing before the correct diagnosis result is communicated to them by a physician. A specimen collection kit includes everything needed to secure a sample and send it to a laboratory for diagnostics, environmental sampling, and research. Using a kit eliminates confusion about which swab should be paired with which transport media to ensure sample viability during transport.

Global Specimen Collection Kit Market Dynamics

Drivers

• Increasing number of laboratory tests

Laboratory tests provide vital information about a patient's health. The accuracy of test results is critical in making accurate diagnostic and therapeutic decisions. Accurate test results necessitate proper patient preparation, specimen collection, and specimen handling. The integrity of the specimens determines the accuracy of the test results. Laboratory tests are medical tests that use a variety of laboratory equipment to gather information about a patient's health. These tests necessitate the collection of blood, urine, or other samples from patients in order to diagnose their specific medical condition and determine the best course of treatment. Clinical microbiology, clinical chemistry, haematology, DNA testing, and reproductive biology tests are among the most important areas of clinical laboratory testing.

Furthermore, the most common clinical laboratory tests are a complete blood count (CBC), a comprehensive metabolic panel, a basic metabolic panel, a liver panel, a lipid panel, HbA1c, HGB/HCT, urinalysis, and thyroid-stimulating hormone. As a result of the various laboratory tests available, the global specimen collection kit market is expected to grow.

Opportunities

• Rising usage of lab tests for disease diagnosis and better healthcare facilities 

According to the American Clinical Laboratory Association, clinical laboratory tests save time, money, and lives by allowing early disease detection and prevention. Over 7 billion clinical lab tests are performed in the United States each year, providing critical data at a low cost. Increased product launches in this region are also expected to drive market growth. For instance, on August 3rd, 2021, Sedia Biosciences, a company based in the United States, released the Asanté DNA Specimen Collection Kit and its companion product, the Asanté DNA Purification Kit. The Asanté DNA Specimen Collection Kit is a low-cost alternative to current methods for DNA specimen collection, with low DNA retention, minimal interfering substances, and ease of use.

Restraints/Challenges

• Problems associated with specimen collection 

Clotting and incorrect volume are two of the most common mistakes made during specimen collection and handling. Extreme temperatures may also cause specimens to be rejected for testing. Clotting compromises a specimen's integrity, rendering it unsuitable for testing. One of the most common problems in specimen collection is the submission of an insufficient volume of specimen for testing. The laboratory issues a QNS (quantity not sufficient) report, and the patient is called for a repeat collection, which is inconvenient for both the patient and the physician.

This specimen collection kit market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the specimen collection kit market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Specimen Collection Kit Market

COVID-19 had positive impact on the specimen collection kit market. At the start of the COVID-19 pandemic, the challenge was to standardize the format of sample data from various tests performed across the country. NIC created the RT-PCR and RATI mobile apps for ICMR and the web portal on Android, iOS, and Windows mobiles to allow phlebotomists (sample collectors) to use the mobile apps web-portal. The RT-PCR App, for instance, is a handheld tool for Medical Staff at Sample Collection Centers across the country. The Sample Collection Facility will send samples from various specimens to ICMR labs for COVID-19 confirmation using the RT-PCR test. The ICMR was notified ahead of time via the app. As a result, the market is expected to expand during COVID-19.

Recent developments

• On September 28th, 2021, Thermo Fisher Scientific launched the Thermo Scientific SpeciMAX Stabilized Saliva Collection Kit to collect saliva safely for research purposes. The SpeciMAX Stabilized Saliva Collection Kit preserves viral nucleic acids in a non-hazardous stabilisation solution that inactivates common respiratory viruses for safer sample collection. A spill-resistant funnel, a screw cap to secure the sample after collection, and a standardized size tube that fits seamlessly into viral RNA extraction automation workflows for high throughput sample processing are all included in the kit.
• On June 1, 2020, EKF Diagnostics received new contracts for producing and supplying a novel, patented sample collection device that allows COVID-19 samples to be rapidly inactivated in the collection tube, avoiding contamination and preserving RNA without the need for refrigeration.

Global Specimen Collection Kit Market Scope

The specimen collection kit market is segmented on the basis of product, site of collection, application, end-user and sample types. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Swabs
• Nasopharyngeal (NP) Swabs
• Oropharyngeal (OP) Swabs
• Nasal Swabs
• Viral Transport Media
• Blood Collection Kits
• Other Consumables

Site of Collection

• Hospitals and Clinics
• Home Test

Application

• Diagnostics
• Research

 End-User

• Hospitals and Clinics
• Diagnostic Centers
• Others

 Sample Types

• Male
• Urethral swab
• Urine
• Female
• Endocervical swab
• Vaginal swab
• Urine

Specimen Collection Kit Market Regional Analysis/Insights

The specimen collection kit market is analyzed and market size insights and trends are provided by country, product, site of collection, application, end-user and sample types as referenced above.

The countries covered in the specimen collection kit market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the specimen collection kit market due to high uptake of medical sterile swabs and specimen collection kits.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the rise in government funding.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The specimen collection kit market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for specimen collection kit market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the specimen collection kit market. The data is available for historic period 2011-2021.

Competitive Landscape and Specimen Collection Kit Market Share Analysis

The specimen collection kit market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to specimen collection kit market.

Some of the major players operating in the specimen collection kit market are:

• Thermo Fisher Scientific Inc. (U.S.)
• Puritan Medical Products (U.S.)
• BD (U.S.)
• Laboratory Corporation of America Holdings (U.S.)
• Lucence Health Inc. (Singapore)
• Hardy Diagnostics (U.S.)
• BTNX (Canada)
• Formlabs (U.S.)
• Medline Industries, Inc. (U.S.)
• VIRCELL S.L. (Spain)
• HiMedia Laboratories (India)
• Titan Biotech (India)
• McDermott Will & Emery (U.S.)
• Miraclean Technology Co. Ltd (China)
• Starplex Scientific Inc. (Canada)
• DiaSorin Molecular LLC (U.S.)

SKU-56811